MiMedx Group Balance Sheet Health
Financial Health criteria checks 6/6
MiMedx Group has a total shareholder equity of $181.0M and total debt of $19.0M, which brings its debt-to-equity ratio to 10.5%. Its total assets and total liabilities are $243.9M and $62.9M respectively. MiMedx Group's EBIT is $63.7M making its interest coverage ratio 21.2. It has cash and short-term investments of $88.8M.
Key information
10.5%
Debt to equity ratio
US$19.02m
Debt
Interest coverage ratio | 21.2x |
Cash | US$88.80m |
Equity | US$181.01m |
Total liabilities | US$62.88m |
Total assets | US$243.89m |
Recent financial health updates
We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease
Dec 23We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt
May 14We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt
Jan 05Is MiMedx Group (NASDAQ:MDXG) Using Debt In A Risky Way?
Aug 08Does MiMedx Group (NASDAQ:MDXG) Have A Healthy Balance Sheet?
Apr 22Health Check: How Prudently Does MiMedx Group (NASDAQ:MDXG) Use Debt?
Dec 20Recent updates
We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease
Dec 23We Ran A Stock Scan For Earnings Growth And MiMedx Group (NASDAQ:MDXG) Passed With Ease
Nov 21There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise
Nov 06MiMedx Group, Inc.'s (NASDAQ:MDXG) Shares Bounce 27% But Its Business Still Trails The Industry
May 21We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt
May 14Improved Revenues Required Before MiMedx Group, Inc. (NASDAQ:MDXG) Shares Find Their Feet
Mar 27We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt
Jan 05MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Dec 18Is MiMedx Group (NASDAQ:MDXG) Using Debt In A Risky Way?
Aug 08Does MiMedx Group (NASDAQ:MDXG) Have A Healthy Balance Sheet?
Apr 22Health Check: How Prudently Does MiMedx Group (NASDAQ:MDXG) Use Debt?
Dec 20MiMedx gets Japanese reimbursement approval for its tissue allograft EPIFIX
Sep 12MiMedx Group expects AWC full-year sales in low end of 11%-14% growth range
Sep 06Financial Position Analysis
Short Term Liabilities: MDXG's short term assets ($172.1M) exceed its short term liabilities ($41.9M).
Long Term Liabilities: MDXG's short term assets ($172.1M) exceed its long term liabilities ($20.9M).
Debt to Equity History and Analysis
Debt Level: MDXG has more cash than its total debt.
Reducing Debt: MDXG's debt to equity ratio has reduced from 166.6% to 10.5% over the past 5 years.
Debt Coverage: MDXG's debt is well covered by operating cash flow (303.3%).
Interest Coverage: MDXG's interest payments on its debt are well covered by EBIT (21.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/21 12:47 |
End of Day Share Price | 2025/01/21 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MiMedx Group, Inc. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jason Wittes | Brean Capital |
William Plovanic | Canaccord Genuity |
Ross Osborn | Cantor Fitzgerald & Co. |